A systematic review of cost-effectiveness studies comparing conventional, biological and surgical interventions for inflammatory bowel disease
Background Inflammatory bowel disease (IBD) is a chronic disease placing a large health
and economic burden on health systems worldwide. The treatment landscape is complex …
and economic burden on health systems worldwide. The treatment landscape is complex …
Positioning therapies in ulcerative colitis
Ulcerative colitis (UC) is a chronic, idiopathic inflammatory bowel disease (IBD) that affects
the large intestine. Several therapeutic drug classes are available for the treatment of UC …
the large intestine. Several therapeutic drug classes are available for the treatment of UC …
Role of microRNA in inflammatory bowel disease: clinical evidence and the development of preclinical animal models
The dysregulation of microRNA (miRNA) is implicated in cancer, inflammation,
cardiovascular disorders, drug resistance, and aging. While most researchers study …
cardiovascular disorders, drug resistance, and aging. While most researchers study …
Systematic review with network meta‐analysis: the impact of medical interventions for moderate‐to‐severe ulcerative colitis on health‐related quality of life
Background Patient‐reported outcomes are important in the assessment of efficacy of
intervention for ulcerative colitis (UC). Aim To compare the impact of interventions for …
intervention for ulcerative colitis (UC). Aim To compare the impact of interventions for …
Efficacy and safety of biologic agents and tofacitinib in moderate-to-severe ulcerative colitis: A systematic overview of meta-analyses
K Pantavou, AI Yiallourou, D Piovani… - United European …, 2019 - journals.sagepub.com
Background Ulcerative colitis (UC) is an inflammatory disease of the colon and rectum.
Treatment options include biologics and tofacitinib. Objectives We aim to summarize the …
Treatment options include biologics and tofacitinib. Objectives We aim to summarize the …
Curcumin-loaded microspheres are effective in preventing oxidative stress and intestinal inflammatory abnormalities in experimental ulcerative colitis in rats
Curcumin's role in the treatment of ulcerative colitis (UC) has been proven by numerous
studies, but its preventive administration, with the aim of reducing the remission episodes …
studies, but its preventive administration, with the aim of reducing the remission episodes …
Impact van de eerste COVID-19 golf op de reguliere zorg en gezondheid: Inventarisatie van de omvang van het probleem en eerste schatting van …
A Van Giessen, A De Wit, C Van den Brink, K Degeling… - 2020 - rivm.openrepository.com
De COVID-19-epidemie heeft tijdens de eerste golf grote impact gehad op de zorg, vooral in
het voorjaar van 2020. Afspraken, behandelingen en operaties voor niet-COVID-patiënten …
het voorjaar van 2020. Afspraken, behandelingen en operaties voor niet-COVID-patiënten …
Methods to compare adverse events in twitter to FAERS, drug information databases, and systematic reviews: proof of concept with adalimumab
Abstract Introduction Adverse drug reactions (ADRs) are associated with significant health-
related and financial burden, and multiple sources are currently utilized to actively discover …
related and financial burden, and multiple sources are currently utilized to actively discover …
Safety of biological therapies in ulcerative colitis: an umbrella review of meta-analyses
S Bonovas, K Pantavou, D Evripidou… - Best practice & research …, 2018 - Elsevier
Biological agents have proven clinical efficacy in the treatment of ulcerative colitis (UC).
Their adverse effects have also been studied in a substantial number of primary studies and …
Their adverse effects have also been studied in a substantial number of primary studies and …
Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation
C Lohan, A Diamantopoulos… - BMJ open …, 2019 - bmjopengastro.bmj.com
Background and aims In the UK, treatments for patients with moderately to severely active
ulcerative colitis who have an inadequate response to conventional therapies comprise four …
ulcerative colitis who have an inadequate response to conventional therapies comprise four …